Herpes Zoster (Shingles) Vaccine

Shingles vaccine protects against herpes zoster (shingles), a painful skin rash caused by reactivation of the varicella-zoster virus. It also prevents postherpetic neuralgia (PHN), a chronic pain condition.

The Herpes Zoster (Shingles) Vaccine is recommended for 50 years and above. It falls under the Adult vaccine category. Consult your doctor to confirm if this vaccine is right for you based on your health history and existing immunity.

The Herpes Zoster (Shingles) Vaccine has an efficacy of Shingrix: 90%+ effective against shingles and PHN. This means it provides significant protection against Herpes Zoster (Shingles) and Postherpetic Neuralgia (PHN). Efficacy may vary based on age, health status, and the specific strain encountered.

Common side effects include: Shingrix: Pain; redness; swelling at injection site; shivering. These are typically mild and resolve within 1–3 days. Serious allergic reactions are rare — if you experience difficulty breathing, hives, or rapid heartbeat after vaccination, seek emergency care immediately.

The Herpes Zoster (Shingles) Vaccine should be avoided by: Shingrix: Severe allergic reaction to prior dose. Zostavax: Immunosuppressed individuals; pregnancy.. Always inform your healthcare provider of your full medical history before vaccination.

The Herpes Zoster (Shingles) Vaccine typically costs ₹8,000–₹12,000 per dose (Shingrix) in India. Government health centres may offer it free or at subsidised prices for eligible age groups. Private hospitals and clinics may charge differently. Additional fees may apply for administration.